Evidence map›Paper›PMID 31613720›Full record

ArticleJournal of oncology practice2019

Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center.

Donna S Zhukovsky, Pamela T Soliman, Boby Mathew, Sarah Mills, Diane Bodurka, Michael Frumovitz, Larissa A Meyer, Shannon Westin, Marisa Nowitz, LaShan Archie and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of oncology practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 5 countries.

Donna S ZhukovskyThe University of Texas MD Anderson Cancer Center, Houston, TX.
Pamela T SolimanThe University of Texas MD Anderson Cancer Center, Houston, TX.
Boby MathewThe University of Texas MD Anderson Cancer Center, Houston, TX.
Sarah MillsSeton Medical Center and University of Texas, Austin, TX.
Diane BodurkaThe University of Texas MD Anderson Cancer Center, Houston, TX.
Michael FrumovitzThe University of Texas MD Anderson Cancer Center, Houston, TX.
Larissa A MeyerThe University of Texas MD Anderson Cancer Center, Houston, TX.
Shannon WestinThe University of Texas MD Anderson Cancer Center, Houston, TX.
Marisa NowitzBaylor College of Medicine and Texas Children's Hospital, Houston, TX.
LaShan ArchieThe University of Texas MD Anderson Cancer Center, Houston, TX.
Shauna FentonThe University of Texas MD Anderson Cancer Center, Houston, TX.
Kai LangThe University of Texas MD Anderson Cancer Center, Houston, TX.
Janet L WilliamsThe University of Texas MD Anderson Cancer Center, Houston, TX.
Valentine BovingThe University of Texas MD Anderson Cancer Center, Houston, TX.
Eduardo BrueraThe University of Texas MD Anderson Cancer Center, Houston, TX.
Pfizer (United States) · USAstraZeneca (Finland) · FIKaryopharm Therapeutics (United States) · USTesaro (United States) · USTheranostics (New Zealand) · NZBayer (United States) · USLanner Group (United Kingdom) · GBMerck (Germany) · DENovartis (Germany) · DE

Funding

Health Services Career Development: Improving Medical Decisions in Ovarian CancerK07CA201013 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MEYER, LARISSA ALEJANDRA · 2016 to 2020
$853k
NCI NIH HHS K07 CA201013
6 · The paper itself

Abstract

purposeAdvance care planning (ACP) supports national priorities of patient engagement, person-centered care, and safety. A systematic approach is uncommon in most care settings. Our institution offers all patients with cancer new to the institution an opportunity to select and prepare a medical decision maker (MDM) after social work counseling. The goals of this study were to determine the success of a systematic institutional process for selecting a prepared MDM. The primary objectives were that (1) 70% or more of new patients would have one or more documented social work ACP discussions by the third office visit within 4 months, and (2) there would be a two-fold increase in scanned medical power of attorney (MPOA) documents available in the electronic health record (EHR). The secondary objectives were (1) improved surrogate preparedness for medical decision making, and (2) to determine whether patients with metastatic disease demonstrated greater readiness for selection of an MDM than those with localized disease. MATERIALS AND

methodsWe conducted a retrospective chart review of consecutive gynecology oncology outpatients.

resultsOf 133 patients, 93 (70%) had metastatic disease. The median number of visits was two (one to three). Forty-seven patients (39.3%) met with social work by visit 3. Review of ACP notes suggested that most patients were in the early stages of selecting a prepared MDM. At visit 1, 39 (29.3%) reported having an advance directive document; 14 (10.5%) had an MPOA in the EHR. There was no increase by visit 3. Fewer patients with metastatic disease than those with localized cancer (32.3%

conclusionCurrent processes fail to engage patients in selecting and preparing an MDM.

Indexed as

Clinical Decision-MakingAdvance DirectivesDocumentationElectronic Health RecordsFemaleGenital Neoplasms, FemaleHumansMedical OncologyOutpatientsPatient ParticipationRetrospective Studies

Identifiers

PMID31613720
PMCPMC7846063
OpenAlexW2980336349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.